Dividends CalendarEarnings Calendar

IMRN | Immuron


Company profile

  • Industry: Biotechnology
  • Sector: Healthcare
  • Headquarters:   Blackburn North, Australia

Company profile

Immuron Ltd (ASX:IMC) (NASDAQ:IMRN) is a microbiome company focused on developing and commercialising oral immunotherapeutics for the treatment of many gut mediated diseases. Immuron has a unique and safe technology platform that enables a shorter development therapeutic cycle.

About the Company

Anadis is a biotechnology company based in Melbourne, Australia. In 2008 Anadis changed its name to Immuron Ltd. The company focused on antigen-primed, dairy-derived health products.


    Building 10, 25-37 Chapman Street, Blackburn North, VIC 3131 Australia

    Products & Services

    • Travelan®

    • Protectyn®

      Jump to (Finance sites)

      Their Official Profiles 


      Support this project

      If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
      More features coming soon :)

      Social Media 

      Recommended Books

      The Intelligent Investor
      Buy on Amazon

      Graham's philosophy of "value investing" has made The Intelligent Investor the stock market bible ever since its original publication in 1949.

      The best book on investing ever written.
      -- Warren Buffet